- Québec marks Valens’ 8th provincial distribution supply agreement
- The Valens Company products will soon be available to over 95% of the Canadian population1
KELOWNA, BC, Oct. 18, 2021 /PRNewswire/ – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company,” “The Valens Company” or “Valens”), a leading manufacturer of cannabis products, today announced that it has executed a letter of intent with Société québécoise du cannabis (“SQDC”) for the distribution of its cannabis products into Québec. This marks a significant milestone for Valens entering the third-largest cannabis market in Canada, representing approximately 15% of Canadian cannabis retail sales2 in the country and approximately 22% of the Canadian population.3
We are pleased to announce the entrance into the Québec marketplace. This an important milestone for The Valens Company with a national distribution platform that now makes our products accessible to over 95% of the Canadian population.
Tyler Robson, Chief Executive Officer, Co-Founder, and Chair of The Valens Company
This letter of intent showcases our innovation and consumers should expect new product offerings coming to the Québec marketplace soon. We expect our products to be first available at the beginning of 2022.
At Valens, it’s Personal.
1 Statistics Canada
2 Statistics Canada, July 2021 cannabis retail sales
3 Statistics Canada
About The Valens Company
The Valens Company is a leading cannabis consumer products company, with significant expertise in manufacturing cannabinoid based products and a mission to bring the benefits of cannabis to the world. Valens provides proprietary cannabis processing services and best-in-class product development, manufacturing, and commercialization of cannabis consumer packaged goods. Valens’ high-quality products are formulated for the recreational, health and wellness, and medical consumer segments and are offered across all cannabis product categories, with a focus on quality and product innovation. Valens also manufactures, distributes, and sells a wide range of CBD products in the United States through its subsidiary Green Roads, and distributes medicinal cannabis products to international markets through its subsidiary Valens Australia. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, Valens continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences. Through Valens Labs, Valens is setting the standard in cannabis testing and research and development with Canada’s only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific. Discover more on The Valens Company at http://www.thevalenscompany.com.
